Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc. > New products distributed by cc pharma
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1223)
•••
Comment by ProfCorneliuson Apr 25, 2020 10:19am
293 Views
Post# 30952942

RE:New products distributed by cc pharma

RE:New products distributed by cc pharma
AlbertOyler wrote: CannRelief is the CBD-based cosmetics line for the German market. New products include additives to cbd oil, day and night cream, body oil, capsules.
https://cannrelief.de/pages/shop
[/quote

Thanks Albert!!

The launch of Irwin's vision of Aphria becoming a CPG company has begun!

CC Pharma's numbers next Q will shatter any previous record Q that it has had.
Soon, we will be pumping more and more Aphria brands and products through CC's 13 000 pharmacy pipeline. Aphria's revs are only going to ramp up more and more from here.

We have a great thing growing!
Prof

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities